IMMUNE CHECKPOINT INHIBITOR
Clinical trials for IMMUNE CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in slowing advanced prostate cancer
Disease control CompletedThis study tested whether adding a new immunotherapy drug, lorigerlimab, to standard chemotherapy (docetaxel) could help men with a hard-to-treat type of advanced prostate cancer live longer without their disease getting worse. About 154 men took part, receiving either the drug c…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
Heart alert: blood test may catch immunotherapy side effects early
Knowledge-focused CompletedThis study looked at 300 cancer patients treated with immune checkpoint inhibitors to see if measuring troponin (a heart protein) in the blood can help detect serious heart problems early. The goal was to find out if this monitoring helps prevent heart attacks, strokes, or other …
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Sponsor: Institut Mutualiste Montsouris • Aim: Knowledge-focused
Last updated May 04, 2026 16:24 UTC